This report is on how to support governments and industry in building a sustainable bio-based economy. The OECD Task Force on Industrial Biotechnology is considering the development of a set of recommendations in the area of Environmental and Economic Sustainability.
The key goal of the current work is to identify further means (e.g. international guidelines, policy recommendations) to implement the 2004 OECD Science and Technology Ministers mandate on “Biotechnology for Sustainable Growth and Development” .
This July 2009 symposium brought together the different communities – scientific, engineering, policy, public and legal – involved in synthetic biology and explored the opportunities and challenges posed by this emerging field.
Workshop discussions were structured around a set of issues papers – one for each of the sessions. The workshop was set up as a working roundtable discussion. 50 participants familiar with data sources for industrial biotechnology attended the workshop.
English, , 287kb
The aim of these guidelines is to propose a harmonised approach for the collection and analysis of biotechnology research and development (R&D) statistics in the government and higher education sectors.
This book reviews how the emergence of pharmacogenetics will impact the efficiency of pharmaceutical R&D and improve healthcare decision making and clinical care. It discusses what policies need to change in order for the public to reap the benefits from advances in diagnostic genetic testin
The ability to effectively use these vast amounts of knowledge will depend in part on the bringing together of different strands of information, data and biological materials within human biobanks and genetic research databases (HBGRDs).
The workshop discussed existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels.
Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms.
English, , 2,570kb
The 2009 edition brings together the latest available economic and activity data on biotechnology and innovation for 22 OECD members and four non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.